BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17572714)

  • 1. Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
    Patah PA; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall EJ
    Bone Marrow Transplant; 2007 Aug; 40(4):365-8. PubMed ID: 17572714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
    Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
    Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial contamination of hematopoietic progenitor cell products.
    Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
    Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts.
    Kamble R; Pant S; Selby GB; Kharfan-Dabaja MA; Sethi S; Kratochvil K; Kohrt N; Ozer H
    Transfusion; 2005 Jun; 45(6):874-8. PubMed ID: 15934984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.
    Reich-Slotky R; Wu F; Della-Latta P; Savage DG; Schwartz J
    Transfusion; 2008 Nov; 48(11):2409-13. PubMed ID: 18657076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous transplant: microbial contamination of hematopoietic stem cell products.
    Almeida ID; Schmalfuss T; Röhsig LM; Goldani LZ
    Braz J Infect Dis; 2012; 16(4):345-50. PubMed ID: 22846122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant.
    Majado MJ; García-Hernández A; Morales A; González C; Martínez-Sánchez V; Menasalvas A; Rosique P; Rubio A; Sanz-Imedio E
    Bone Marrow Transplant; 2007 Jan; 39(2):121-5. PubMed ID: 17173054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products.
    Padley DJ; Dietz AB; Gastineau DA
    Transfusion; 2007 Apr; 47(4):636-43. PubMed ID: 17381622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial contamination of peripheral blood stem cell collections.
    Attarian H; Bensinger WI; Buckner CD; McDonald DL; Rowley SD
    Bone Marrow Transplant; 1996 May; 17(5):699-702. PubMed ID: 8733684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
    Lowder JN; Whelton P
    Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation.
    Larrea L; de la Rubia J; Soler MA; Ribas P; Fernández JM; Picón I; García-Boyero R; García-Bellés C; Roig R
    Haematologica; 2004 Oct; 89(10):1232-7. PubMed ID: 15477209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
    Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
    Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts.
    Vanneaux V; Foïs E; Robin M; Rea D; de Latour RP; Biscay N; Chantre E; Robert I; Wargnier A; Traineau R; Benbunan M; Marolleau J; Socié G; Larghero J
    Cytotherapy; 2007; 9(5):508-13. PubMed ID: 17786612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How much GMP do we need to infuse contaminated HPC and DLI products?
    Forte L; Gardiner N; O'Connell B; McCann SR
    Bone Marrow Transplant; 2007 Aug; 40(4):389-90. PubMed ID: 17572717
    [No Abstract]   [Full Text] [Related]  

  • 15. What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?
    Kelly M; Roy DC; Labbe AC; Laverdiere M
    Bone Marrow Transplant; 2006 Aug; 38(3):183-8. PubMed ID: 16785868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial contamination of harvested bone marrow and peripheral blood.
    Prince HM; Page SR; Keating A; Saragosa RF; Vukovic NM; Imrie KR; Crump M; Stewart AK
    Bone Marrow Transplant; 1995 Jan; 15(1):87-91. PubMed ID: 7742761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?
    Dal MS; Tekgündüz E; Çakar MK; Kaya AH; Namdaroğu S; Batgi H; Bekdemir F; Uncu Ulu B; Yiğenoğlu TN; Kılınç A; İskender D; Uğur B; Koçubaba Ş; İskender G; Altuntaş F
    Transfus Apher Sci; 2016 Aug; 55(1):125-8. PubMed ID: 27184293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic cells for autologous transplantation.
    Nifong TP; Ehmann WC; Mierski JA; Domen RE; Rybka WB
    Arch Pathol Lab Med; 2003 Jan; 127(1):e19-21. PubMed ID: 12562288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
    Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
    Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.
    Castagnola E; Faraci M
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):607-21. PubMed ID: 19485800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.